Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking

Neuropsychopharmacology

Volumn 39, Issue 10, 2014, Pages 2299-2308

  Pei, Yui ^a   Lee, Jungah ^a   Leo, Damiana ^b   Gainetdinov, Raul R ^b,c,d   Hoener, Marius C ^e   Canales, Juan J ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^d ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; COCAINE; DOPAMINE; RECEPTOR; RO 5203648; RO 5256390; TRACE AMINE ASSOCIATED RECEPTOR 1; UNCLASSIFIED DRUG; 4-(3,4-DICHLOROPHENYL)-4,5-DIHYDROOXAZOL-2-YLAMINE; CENTRAL NERVOUS SYSTEM AGENTS; DOPAMINE UPTAKE INHIBITOR; G PROTEIN COUPLED RECEPTOR; OXAZOLE DERIVATIVE; TRACE AMINE-ASSOCIATED RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CYCLIC POTENTIOMETRY; DRUG ACTIVITY; DRUG SEEKING BEHAVIOR; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; AGONISTS; ANIMAL; CHRONIC DISEASE; COCAINE-RELATED DISORDERS; DOSE RESPONSE; DRUG EFFECTS; DRUG SELF ADMINISTRATION; LONG EVANS RAT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; REINFORCEMENT;

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; CHRONIC DISEASE; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; MALE; NUCLEUS ACCUMBENS; OXAZOLES; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS; RECEPTORS, G-PROTEIN-COUPLED; SELF ADMINISTRATION;

EID: 84906313910     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.88     Document Type: Article

References (43)

1. Berry MD (2004). Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90: 257-271
2. Berry MD (2007). The potential of trace amines and their receptors for treating neurological and psychiatric diseases. Rev Recent Clin Trials 2: 3-19
3. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL et al (2001). Trace amines: Identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98: 8966-8971
4. Bradaia A, Trube G, Stalder H, Norcross RD, Ozmen L, Wettstein JG et al (2009). The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci USA 106: 20081-20086
5. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI et al (2001). Amphetamine, 3, 4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60: 1181-1188
6. Cornish JL, Kalivas PW (2000). Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20: RC89
7. de WH, Stewart J (1981). Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berl) 75: 134-143
8. Espinoza S, Salahpour A, Masri B, Sotnikova TD, Messa M, Barak LS et al (2011). Functional interaction between trace amineassociated receptor 1 and dopamine D2 receptor. Mol Pharmacol 80: 416-425
9. Ferragud A, Velazquez-Sanchez C, Hernandez-Rabaza V, Nacher A, Merino V, Carda M et al (2009). A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-Administration in the rat. Psychopharmacology (Berl) 207: 281-289
10. Fontana DJ, Post RM, Pert A (1993). Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res 629: 31-39
11. Fuchs RA, Branham RK, See RE (2006). Different neural substrates mediate cocaine seeking after abstinence versus extinction training: A critical role for the dorsolateral caudate-putamen. J Neurosci 26: 3584-3588
12. Grandy DK (2007). Trace amine-Associated receptor 1-family archetype or iconoclast? Pharmacol Ther 116: 355-390
13. Greco PG, Garris PA (2003). In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry. Eur J Pharmacol 479: 117-125
14. Hearing MC, Miller SW, See RE, McGinty JF (2008a). Relapse to cocaine seeking increases activity-regulated gene expression differentially in the prefrontal cortex of abstinent rats. Psychopharmacology (Berl) 198: 77-91
15. Hearing MC, See RE, McGinty JF (2008b). Relapse to cocaineseeking increases activity-regulated gene expression differentially in the striatum and cerebral cortex of rats following short or long periods of abstinence. Brain Struct Funct 213: 215-227
16. John CE, Jones SR (2007). Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 52: 1596-1605
17. Kalivas PW (2008). Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry. Neurotox Res 14: 185-189
18. Kalivas PW, McFarland K (2003). Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168: 44-56
19. Karila L, Petit A, Lowenstein W, Reynaud M (2012). Diagnosis and consequences of cocaine addiction. Curr Med Chem 19: 5612-5618
20. Kawagoe KT, Zimmerman JB, Wightman RM (1993). Principles of voltammetry and microelectrode surface states. J Neurosci Methods 48: 225-240
21. Koob GF, Le MM (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97-129
22. Kuhr WG, Wightman RM (1986). Real-Time measurement of dopamine release in rat brain. Brain Res 381: 168-171
23. Ledonne A, Federici M, Giustizieri M, Pessia M, Imbrici P, Millan MJ et al (2010). Trace amines depress D(2)-Autoreceptormediated responses on midbrain dopaminergic cells. Br J Pharmacol 160: 1509-1520
24. Lewin AH, Miller GM, Gilmour B (2011). Trace amine-Associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class. Bioorg Med Chem 19: 7044-7048
25. Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC (2005). Trace amine-Associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85: 372-385
26. Lindemann L, Hoener MC (2005). A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol Sci 26: 274-281
27. Lindemann L, Meyer CA, Jeanneau K, Bradaia A, Ozmen L, Bluethmann H et al (2008). Trace amine-Associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther 324: 948-956
28. McFarland K, Lapish CC, Kalivas PW (2003). Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaineinduced reinstatement of drug-seeking behavior. J Neurosci 23: 3531-3537
29. Melis M, Spiga S, Diana M (2005). The dopamine hypothesis of drug addiction: Hypodopaminergic state. Int Rev Neurobiol 63: 101-154
30. Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H et al (2005). Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther 313: 983-994
31. Park WK, Bari AA, Jey AR, Anderson SM, Spealman RD, Rowlett JK et al (2002). Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci 22: 2916-2925
32. Phillips PE, Stuber GD, Heien ML, Wightman RM, Carelli RM (2003). Subsecond dopamine release promotes cocaine seeking. Nature 422: 614-618
33. Reese EA, Norimatsu Y, Grandy MS, Suchland KL, Bunzow JR, Grandy DK (2014). Exploring the determinants of trace amineassociated receptor 1's functional selectivity for the stereoisomers of amphetamine and methamphetamine. J Med Chem 57: 378-390
34. Revel FG, Meyer CA, Bradaia A, Jeanneau K, Calcagno E, Andre CB et al (2012a). Brain-specific overexpression of trace amineassociated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine. Neuropsychopharmacology 37: 2580-2592
35. Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R et al (2011). TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci USA 108: 8485-8490
36. Revel FG, Moreau JL, Gainetdinov RR, Ferragud A, Velazquez-Sanchez C, Sotnikova TD et al (2012b). Trace amine-Associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry 72: 934-942
37. Revel FG, Moreau JL, Pouzet B, Mory R, Bradaia A, Buchy D et al (2013). A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic-And antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry 18: 543-556
38. Richardson NR, Roberts DC (1996). Progressive ratio schedules in drug self-Administration studies in rats: A method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1-11
39. Schenk S, Hely L, Gittings D, Lake B, Daniela E (2008). Effects of priming injections of MDMA and cocaine on reinstatement of. Drug Alcohol Depend 96: 249-255
40. Velazquez-Sanchez C, Ferragud A, Ramos-Miguel A, Garcia-Sevilla JA, Canales JJ (2013). Substituting a long-Acting dopamine uptake inhibitor for cocaine prevents relapse to cocaine seeking. Addict Biol 18: 633-643
41. Xie Z, Miller GM (2007). Trace amine-Associated receptor 1 is a modulator of the dopamine transporter. J Pharmacol Exp Ther 321: 128-136
42. Xie Z, Westmoreland SV, Bahn ME, Chen GL, Yang H, Vallender EJ et al (2007). Rhesus monkey trace amine-Associated receptor 1 signaling: Enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J Pharmacol Exp Ther 321: 116-127
43. Yorgason JT, Espana RA, Jones SR (2011). Demon voltammetry and analysis software: Analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202: 158-164